COVID-19 Impact on a-blocker Market, Global Research Reports 2020-2021
Table of Contents1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on a-blocker Industry
1.7 COVID-19 Impact: a-blocker Market Trends
2 Global a-blocker Quarterly Market Size Analysis
2.1 a-blocker Business Impact Assessment - COVID-19
2.1.1 Global a-blocker Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global a-blocker Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global a-blocker Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 Global a-blocker Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global a-blocker Factory Price by Manufacturers
3.3 Location of Key Manufacturers a-blocker Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into a-blocker Market
3.5 Key Manufacturers a-blocker Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on a-blocker Segments, By Type
4.1 Introduction
1.4.1 Non-selective Antagonists
1.4.2 Selective Antagonists
4.2 By Type, Global a-blocker Market Size, 2019-2021
4.2.1 By Type, Global a-blocker Market Size by Type, 2020-2021
4.2.2 By Type, Global a-blocker Price, 2020-2021
5 Impact of Covid-19 on a-blocker Segments, By Application
5.1 Overview
5.5.1 Hypertension
5.5.2 Raynaud's Disease
5.5.3 Erectile Dysfunction
5.2 By Application, Global a-blocker Market Size, 2019-2021
5.2.1 By Application, Global a-blocker Market Size by Application, 2019-2021
5.2.2 By Application, Global a-blocker Price, 2020-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Business Overview
7.1.2 Pfizer a-blocker Quarterly Production and Revenue, 2020
7.1.3 Pfizer a-blocker Product Introduction
7.1.4 Pfizer Response to COVID-19 and Related Developments
7.2 Novartis
7.2.1 Novartis Business Overview
7.2.2 Novartis a-blocker Quarterly Production and Revenue, 2020
7.2.3 Novartis a-blocker Product Introduction
7.2.4 Novartis Response to COVID-19 and Related Developments
7.3 Merck
7.3.1 Merck Business Overview
7.3.2 Merck a-blocker Quarterly Production and Revenue, 2020
7.3.3 Merck a-blocker Product Introduction
7.3.4 Merck Response to COVID-19 and Related Developments
7.4 Astra Zeneca
7.4.1 Astra Zeneca Business Overview
7.4.2 Astra Zeneca a-blocker Quarterly Production and Revenue, 2020
7.4.3 Astra Zeneca a-blocker Product Introduction
7.4.4 Astra Zeneca Response to COVID-19 and Related Developments
7.5 Jhonson and Johnson
7.5.1 Jhonson and Johnson Business Overview
7.5.2 Jhonson and Johnson a-blocker Quarterly Production and Revenue, 2020
7.5.3 Jhonson and Johnson a-blocker Product Introduction
7.5.4 Jhonson and Johnson Response to COVID-19 and Related Developments
7.6 Eli Lilly
7.6.1 Eli Lilly Business Overview
7.6.2 Eli Lilly a-blocker Quarterly Production and Revenue, 2020
7.6.3 Eli Lilly a-blocker Product Introduction
7.6.4 Eli Lilly Response to COVID-19 and Related Developments
7.7 Sanofi
7.7.1 Sanofi Business Overview
7.7.2 Sanofi a-blocker Quarterly Production and Revenue, 2020
7.7.3 Sanofi a-blocker Product Introduction
7.7.4 Sanofi Response to COVID-19 and Related Developments
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Business Overview
7.8.2 Bristol-Myers Squibb a-blocker Quarterly Production and Revenue, 2020
7.8.3 Bristol-Myers Squibb a-blocker Product Introduction
7.8.4 Bristol-Myers Squibb Response to COVID-19 and Related Developments
7.9 Bayer
7.9.1 Bayer Business Overview
7.9.2 Bayer a-blocker Quarterly Production and Revenue, 2020
7.9.3 Bayer a-blocker Product Introduction
7.9.4 Bayer Response to COVID-19 and Related Developments
7.10 GSK
7.10.1 GSK Business Overview
7.10.2 GSK a-blocker Quarterly Production and Revenue, 2020
7.10.3 GSK a-blocker Product Introduction
7.10.4 GSK Response to COVID-19 and Related Developments
7.11 Teva Pharmaceutical
7.11.1 Teva Pharmaceutical Business Overview
7.11.2 Teva Pharmaceutical a-blocker Quarterly Production and Revenue, 2020
7.11.3 Teva Pharmaceutical a-blocker Product Introduction
7.11.4 Teva Pharmaceutical Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
8.1 a-blocker Supply Chain Analysis
8.1.1 a-blocker Supply Chain Analysis
8.1.2 Covid-19 Impact on a-blocker Supply Chain
8.2 Distribution Channels Analysis
8.2.1 a-blocker Distribution Channels
8.2.2 Covid-19 Impact on a-blocker Distribution Channels
8.2.3 a-blocker Distributors
8.3 a-blocker Customers
9 Key Findings
10 Appendix
10.1 About Us
10.2 Disclaimer
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on a-blocker Assessment
Table 9. COVID-19 Impact: a-blocker Market Trends
Table 10. COVID-19 Impact Global a-blocker Market Size
Table 11. Global a-blocker Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global a-blocker Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global a-blocker Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global a-blocker Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global a-blocker Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global a-blocker Market Growth Drivers
Table 17. Global a-blocker Market Restraints
Table 18. Global a-blocker Market Opportunities
Table 19. Global a-blocker Market Challenges
Table 20. Key Manufacturers a-blocker Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, a-blocker Market Size, 2019 (K Units) & (US$ Million)
Table 22. a-blocker Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers a-blocker Manufacturing Plants
Table 24. Key Manufacturers a-blocker Market Served
Table 25. Date of Key Manufacturers Enter into a-blocker Market
Table 26. Key Manufacturers a-blocker Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global a-blocker Market Size by Type, 2020, (US$ Million)
Table 29. Global a-blocker Market Size by Type, 2020 (K Units)
Table 30. Global a-blocker Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global a-blocker Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global a-blocker Market Size by Application, 2020-2021 (K Units)
Table 33. Global a-blocker Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global a-blocker Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global a-blocker Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America a-blocker Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America a-blocker Market Size, 2019-2021 (K Units)
Table 38. US a-blocker Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada a-blocker Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe a-blocker Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe a-blocker Market Size, 2019-2021 (K Units)
Table 43. Germany a-blocker Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France a-blocker Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK a-blocker Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy a-blocker Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific a-blocker Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific a-blocker Market Size, 2019-2021 (K Units)
Table 50. China a-blocker Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan a-blocker Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea a-blocker Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India a-blocker Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN a-blocker Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America a-blocker Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa a-blocker Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Pfizer Business Overview
Table 58. Pfizer a-blocker Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Pfizer a-blocker Product
Table 60. Pfizer Response to COVID-19 and Related Developments
Table 61. Novartis Business Overview
Table 62. Novartis a-blocker Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Novartis a-blocker Product
Table 64. Novartis Response to COVID-19 and Related Developments
Table 65. Merck Business Overview
Table 66. Merck a-blocker Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Merck a-blocker Product
Table 68. Merck Response to COVID-19 and Related Developments
Table 69. Astra Zeneca Business Overview
Table 70. Astra Zeneca a-blocker Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Astra Zeneca a-blocker Product
Table 72. Astra Zeneca Response to COVID-19 and Related Developments
Table 73. Jhonson and Johnson Business Overview
Table 74. Jhonson and Johnson a-blocker Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Jhonson and Johnson a-blocker Product
Table 76. Jhonson and Johnson Response to COVID-19 and Related Developments
Table 77. Eli Lilly Business Overview
Table 78. Eli Lilly a-blocker Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Eli Lilly a-blocker Product
Table 80. Eli Lilly Response to COVID-19 and Related Developments
Table 81. Sanofi Business Overview
Table 82. Sanofi a-blocker Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Sanofi a-blocker Product
Table 84. Sanofi Response to COVID-19 and Related Developments
Table 85. Bristol-Myers Squibb Business Overview
Table 86. Bristol-Myers Squibb a-blocker Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Bristol-Myers Squibb a-blocker Product
Table 88. Bristol-Myers Squibb Response to COVID-19 and Related Developments
Table 89. Bayer Business Overview
Table 90. Bayer a-blocker Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Bayer a-blocker Product
Table 92. Bayer Response to COVID-19 and Related Developments
Table 93. GSK Business Overview
Table 94. GSK a-blocker Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. GSK a-blocker Product
Table 96. GSK Response to COVID-19 and Related Developments
Table 97. Teva Pharmaceutical Business Overview
Table 98. Teva Pharmaceutical a-blocker Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Teva Pharmaceutical a-blocker Product
Table 100. Teva Pharmaceutical Response to COVID-19 and Related Developments
Table 101. a-blocker Distributors List
Table 102. a-blocker Customers List
Table 103. Covid-19 Impact on a-blocker Customers
List of FiguresFigure 1. a-blocker Product Picture
Figure 2. a-blocker Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global a-blocker Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global a-blocker Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global a-blocker Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global a-blocker Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global a-blocker Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global a-blocker Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific a-blocker Market Size Market Share, 2019-2021